Compound Name (alphabetical) | Enz. Inhib. Data | ITC Data | Binding Targets | Alternate Compound Names |
---|
Ki | IC50 | Kd | EC50 | Koff | Kon | Other |
---|
BDBM101262
| 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Amine oxidase [flavin-containing] A
- Amine oxidase [flavin-containing] B
- Lysine-specific histone demethylase 1A
| - US8524717, 17
- US8524717, 32
|
BDBM102131
| 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| |
BDBM102133
| 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| - CHEMBL2435408
- US8530648, 30
|
BDBM102136
| 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| |
BDBM102168
| 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| |
BDBM102169
| 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| |
BDBM102171
| 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| |
BDBM102172
| 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| |
BDBM102173
| 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| |
BDBM102336
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Egl nine homolog 1
- Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
- Vascular endothelial growth factor A
| - US8536181, C17
- US9278930, C17
|
BDBM102337
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Egl nine homolog 1
- Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
- Vascular endothelial growth factor A
| - US8536181, C35
- US9278930, C35
|
BDBM102338
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Egl nine homolog 1
- Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
- Vascular endothelial growth factor A
| - US8536181, C14
- US9278930, C14
|
BDBM102340
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Egl nine homolog 1
- Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
- Vascular endothelial growth factor A
| - US8536181, C33
- US9278930, C33
|
BDBM102341
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Egl nine homolog 1
- Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
- Vascular endothelial growth factor A
| - US8536181, B14
- US9278930, B14
|
BDBM102342
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Egl nine homolog 1
- Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
- Vascular endothelial growth factor A
| - US8536181, C19
- US9278930, C19
|
BDBM102343
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Egl nine homolog 1
- Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
- Vascular endothelial growth factor A
| - US8536181, B9
- US9278930, B9
|
BDBM102344
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Egl nine homolog 1
- Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
- Vascular endothelial growth factor A
| - US8536181, A18
- US9278930, A18
|
BDBM102345
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Egl nine homolog 1
- Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
- Vascular endothelial growth factor A
| - US8536181, D10
- US9278930, D10
|
BDBM102346
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Egl nine homolog 1
- Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
- Vascular endothelial growth factor A
| - US8536181, D14
- US9278930, D14
|
BDBM102347
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Egl nine homolog 1
- Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
- Vascular endothelial growth factor A
| - US8536181, C1
- US9278930, C1
|
BDBM102349
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Egl nine homolog 1
- Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
- Vascular endothelial growth factor A
| - US8536181, E33
- US9278930, E33
|
BDBM102350
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Egl nine homolog 1
- Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
- Vascular endothelial growth factor A
| - US8536181, F3
- US9278930, F3
|
BDBM102351
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Egl nine homolog 1
- Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
- Vascular endothelial growth factor A
| - US8536181, F2
- US9278930, F2
|
BDBM10247
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-2
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
- HSP90 and hnRNPA2/B1
| - 1,2,3,4-tetrahydroisoquinoline-1,3,4-trione
- Isoquinoline-1,3,4-trione 1
- hsp90_153
|
BDBM10332
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(4-Methylthiobenzyl)-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-{[4-(methylsulfanyl)phenyl]methyl}-5-{[(2S)-2-(phenoxymethyl)pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Pyrrolidine Isatin Analogue 11d
|
BDBM10333
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - 4-[(2,3-dioxo-5-{[(2S)-2-(phenoxymethyl)pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indol-1-yl)methyl]phenyl acetate
- Acetic Acid (S)-4-[2,3-Dioxo-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-2,3-dihydroindol-1-yl-methyl]phenyl Ester
- Pyrrolidine Isatin Analogue 11e
|
BDBM10335
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(6-Fluoropyridin-3-yl-methyl)-5-(2-phenoxymethylpyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-[(6-fluoropyridin-3-yl)methyl]-5-{[(2S)-2-(phenoxymethyl)pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Pyrrolidine Isatin Analogue 11g
|
BDBM10336
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(2-Fluoro-pyridin-4-yl-methyl)-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-[(2-fluoropyridin-4-yl)methyl]-5-{[(2S)-2-(phenoxymethyl)pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Pyrrolidine Isatin Analogue 11h
|
BDBM10337
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(6-Fluoro-pyridin-2-yl-methyl)-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-[(6-fluoropyridin-2-yl)methyl]-5-{[(2S)-2-(phenoxymethyl)pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Pyrrolidine Isatin Analogue 11i
|
BDBM10342
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(4-Methylthiobenzyl)-5-(2-phenoxymethyl-azetidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-{[4-(methylsulfanyl)phenyl]methyl}-5-{[(2S)-2-(phenoxymethyl)azetidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Azetidine Isatin Analogue 18d
|
BDBM10343
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(4-Fluorobenzyl)-5-(2-phenoxymethyl-azetidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-[(4-fluorophenyl)methyl]-5-{[(2S)-2-(phenoxymethyl)azetidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Azetidine Isatin Analogue 18e
|
BDBM10344
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(2-Fluorobenzyl)-5-(2-phenoxymethyl-azetidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-[(2-fluorophenyl)methyl]-5-{[(2S)-2-(phenoxymethyl)azetidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Azetidine Isatin Analogue 18f
|
BDBM10345
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(6-Fluoropyridin-3-ylmethyl)-5-(2-phenoxymethyl-azetidine1-sulfonyl)-1H-indole-2,3-dione
- 1-[(6-fluoropyridin-3-yl)methyl]-5-{[(2S)-2-(phenoxymethyl)azetidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Azetidine Isatin Analogue 18g
|
BDBM10346
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(2-Fluoropyridin-4-yl-methyl)-5-(2-phenoxymethyl-azetidine1-sulfonyl)-1H-indole-2,3-dione
- 1-[(2-fluoropyridin-4-yl)methyl]-5-{[(2S)-2-(phenoxymethyl)azetidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Azetidine Isatin Analogue 18h
|
BDBM10347
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(6-Fluoropyridin-2-yl-methyl)-5-(2-phenoxymethyl-azetidine--1-sulfonyl)-1H-indole-2,3-dione
- 1-[(6-fluoropyridin-2-yl)methyl]-5-{[(2S)-2-(phenoxymethyl)azetidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Azetidine Isatin Analogue 18i
|
BDBM103506
| 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - 5-Hydroxytryptamine receptor 6 (5-HT6)
- Potassium voltage-gated channel subfamily H member 2
- Serotonin receptor (2b and 2c)
| - CHEMBL2172186
- US8552017, 1.1(3).HCl
|
BDBM10352
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - 1-(4-Methylthiobenzyl)-5-(2-(pyridin-3-yl-oxymethyl)-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-{[4-(methylsulfanyl)phenyl]methyl}-5-{[(2S)-2-[(pyridin-3-yloxy)methyl]pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Pyridine Analogue 21d
|
BDBM10353
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - 1-(4-Fluorobenzyl)-5-(2-(pyridin-3-yl-oxymethyl)-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-[(4-fluorophenyl)methyl]-5-{[(2S)-2-[(pyridin-3-yloxy)methyl]pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Pyridine Analogue 21e
|
BDBM10354
| 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - 5-(2-(Pyridin-4-yl-oxymethyl)-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 5-{[(2S)-2-[(pyridin-4-yloxy)methyl]pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Pyridine Analogue 23
|
BDBM103748
| 4 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | - Beta-2 adrenergic receptor and beta-3 adrenergic receptor
- Muscarinic acetylcholine receptor M3
| - US8551978, I-15
- US9394275, I-15
- US9572802, Compound I-15
- US9682957, I-15
|
BDBM103755
| 4 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | - Beta-2 adrenergic receptor and beta-3 adrenergic receptor
- Muscarinic acetylcholine receptor M3
| - US8551978, I-23
- US8816088, I-23
- US9394275, I-23
- US9682957, I-23
|
BDBM103774
| 4 | 0 | 0 | 2 | 0 | 0 |